文献速递消化道肿瘤放疗放疗物理与技术姑息放疗与转移瘤

基于知识的自适应计划质量保证:利用剂量学指标用于胰腺癌立体定向自适应放疗

Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer.
PubMed 文献 · Radiother Oncol · 2023-03-07

本研究开发基于知识的工具用于稳健的自适应放疗计划,通过剂量学指标识别胰腺癌立体定向自适应放疗中在线自适应DVH指标变异或计划流程错误。回顾性纳入两个MR-Linac治疗的胰腺癌队列(训练集和验证集),所有患者接受50 Gy分5次。训练集中各DVH指标变异的95%置信区间为PTV及PTV_OPT V95% ±13%、D95% ±5%、D5% ±0.1及±0.03。训练集阳性预测值和阴性预测值分别为77%和89%,验证集两者均为80%。

要点

  • 开发了基于体积的剂量学标识符用于识别自适应计划偏离模拟计划。
  • 训练集阳性预测值77%、阴性预测值89%,验证集两者均为80%。
  • 该技术可能作为自适应放疗临床试验质量保证工具并改善机构整体自适应放疗质量。

核心结论

  • 开发了用于自适应放疗计划质量保证的剂量学指标,可识别胰腺癌立体定向自适应放疗在线自适应过程中基于人群的偏差或计划错误。
  • 该技术可能作为自适应放疗临床试验质量保证工具,并改善机构整体自适应放疗质量。

研究设计与样本

  • 回顾性研究,纳入两个在MR-Linac上治疗胰腺癌的患者队列:训练队列和验证队列。
  • 所有患者接受50 Gy分5次。
  • PTV-OPT通过从PTV中减去危及器官加5 mm外扩生成。

主要发现

  • 训练队列中PTV及PTV_OPT V95%变异的95%置信区间为±13%。
  • 训练队列中PTV及PTV_OPT D95%变异的95%置信区间为±5%。
  • 训练队列中PTV及PTV_OPT D5%变异的95%置信区间分别为±0.1和±0.03。
  • 训练队列阳性预测值为77%,阴性预测值为89%。
  • 验证队列阳性预测值和阴性预测值均为80%。

关键数值与推荐

  • 对训练队列计算每个DVH指标变异的95%置信区间。
  • 训练和验证队列中所有分次DVH指标变异超过95%置信区间者被标记进行回顾性根因分析以确定其识别失效模式的预测能力。
  • 计算的指标包括PTV及PTV_OPT V95%和PTV及PTV_OPT D95%/D5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We aimed to develop knowledge-based tools for robust adaptive radiotherapy (ART) planning to determine on-table adaptive DVH metric variations or planning process errors for stereotactic pancreatic ART. We developed volume-based dosimetric identifiers to identify deviations of ART plans from simulation plans. MATERIALS AND METHODS: Two patient cohorts who were treated on MR-Linac for pancreas cancer were included in this retrospective study; a training cohort and a validation cohort. All patients received 50 Gy in 5 fractions. PTV-OPT was generated by subtracting the critical organs plus a 5 mm-margin from PTV. Several metrics that potentially can identify failure-modes were calculated including PTV & PTV_OPT V95% and PTV & PTV_OPT D95%/D5%. The difference between each DVH metric in each adaptive plan with the DVH metric in simulation plan was calculated. The 95% confidence interval (CI) of the variations in each DVH metric was calculated for the patient training cohort. Variations in DVH metrics that exceeded the 95% CI for all fractions in training and validation cohort were flagged for retrospective investigation for root-cause analysis to determine their predictive power for identifying failure-modes. RESULTS: The CIs for the PTV & PTV_OPT V95% and PTV & PTV_OPT D95%/D5% were ± 13%, ± 5%, ± 0.1, ± 0.03, respectively. We estimated the positive predictive value and negative predictive value of our method to be 77% and 89%, respectively, for the training cohort, and 80% for both in the validation cohort. DISCUSSION: We developed dosimetric indicators for ART planning QA to identify population-based deviations or planning errors during online adaptive process for stereotactic pancreatic ART. This technology may be useful as an ART clinical trial QA tool and improve overall ART quality at an institution.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Forghani F, Ginn JS, Schiff JP, et al. Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer. Radiother Oncol. 2023. PMID: 36889595. doi:10.1016/j.radonc.2023.109603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。